Tech Mahindra, Wipro Individually Partner With NVIDIA at GTC 2025
Tech Mahindra and NVIDIA have announced a collaboration to develop an autonomous pharmacovigilance solution for improving drug safety management. According to the company blog, the solution uses Tech Mahindra’s TENO framework alongside NVIDIA AI Enterprise software, including NeMo, NIM microservices, and AI Blueprints. The solution is being showcased at NVIDIA’s GTC 2025. “AI is ideal for monitoring medicines throughout their lifecycle to support safety. Integrating AI into the Tech Mahindra TENO framework with NVIDIA AI Enterprise software enhances pharmacovigilance by augmenting human capabilities to help identify potential safety issues more effectively,” said John Fanelli, vice president of enterprise software at NVIDIA. The goal is to reduce the risk of human error. The AI system automates pharmacovigilance workflows, handling case intake, data transformation, quality control, and compliance management. In this system, AI agents classify, prioritise, and verify pharmacovigilance emails. According to the companies, the solution can reduce turnaround times by up to 40%, increase data accuracy by 30%, and lower operational costs by 25%. The system processes adverse drug reaction (ADR) cases and supports regulatory compliance through autonomous decision-making. Nikhil Malhotra, chief innovation officer at Tech Mahindra, said the collaboration with NVIDIA will help the pharmaceutical industry manage large volumes of data more efficiently. By applying generative AI and multi-agent systems, they will improve drug safety. “Together, we are revolutionising drug safety management and using the innovative AI-driven framework to develop multiple use cases for our global customers,” Malhotra said Alongside Tech Mahindra, Wipro has also launched sovereign AI services with NVIDIA to help governments and businesses develop country-specific AI solutions. The services use Wipro’s WeGA Studio and NVIDIA AI software to support local language models, data privacy, and AI governance. The applications include healthcare, banking, education, and emergency services, focusing on data security and sovereignty.
While Tech Mahindra aims to enhance drug safety with NVIDIA, Wipro has launched sovereign AI services.
While Tech Mahindra aims to enhance drug safety with NVIDIA, Wipro has launched sovereign AI services.
["NVIDIA"]
["Go", "programming_languages:R", "AI", "innovation", "microservices", "AI agents", "multi-agent systems", "generative AI", "AI governance", "NVIDIA", "R"]
["AI", "generative AI", "multi-agent systems", "microservices", "R", "Go", "AI governance", "innovation", "AI agents", "programming_languages:R"]
I hold a degree in political science, and am interested in how AI and online culture intersect. I am at aditi.suresh@analyticsindiamag.com &amp; x.com/aditisuresh12